The retinoic acid receptor-α agonist SY-1425 can promote the differentiation of acute myeloid leukemia cells with high expression of RARA or IRF8 genes, thereby inhibiting tumor growth (McKeown et al., 2019). This evidence concerns the gene RARA and neoplasm.